Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sorrento Therpt (SRNE)

Sorrento Therpt (SRNE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,326,851
  • Shares Outstanding, K 261,738
  • Annual Sales, $ 31,430 K
  • Annual Income, $ -292,070 K
  • 60-Month Beta 2.61
  • Price/Sales 77.44
  • Price/Cash Flow N/A
  • Price/Book 26.88
Trade SRNE with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.20
  • Number of Estimates 2
  • High Estimate -0.16
  • Low Estimate -0.25
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +52.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.80 +1.02%
on 09/24/20
12.31 -27.78%
on 10/13/20
-0.54 (-5.73%)
since 09/18/20
3-Month
5.77 +54.07%
on 09/04/20
19.39 -54.15%
on 08/10/20
+1.92 (+27.55%)
since 07/17/20
52-Week
1.45 +513.10%
on 11/18/19
19.39 -54.15%
on 08/10/20
+7.36 (+481.05%)
since 10/18/19

Most Recent Stories

More News
3 Top Small-Cap Biotech Stocks To Watch Next Week

Analysts love these small-cap biotech stocks, do you?

PFE : 37.80 (-0.40%)
JNJ : 144.32 (-2.55%)
SRNE : 8.89 (-4.41%)
ALT : 12.19 (-6.01%)
SAVA : 9.84 (-6.11%)
Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Therapeutics' Large Phase 2 Clinical Trial of Abivertinib in Mild, Moderate and Severe COVID-19 Patients

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed with a Phase 2 clinical trial of Abivertinib in mild,...

SRNE : 8.89 (-4.41%)
SmarTrend Watching for Potential Pullback in Shares of Sorrento Therape After 4.56% Gain

Sorrento Therape (NASDAQ:SRNE) traded in a range yesterday that spanned from a low of $11.52 to a high of $12.31. Yesterday, the shares gained 4.6%, which took the trading range above the 3-day high...

SRNE : 8.89 (-4.41%)
Sorrento Adds Mesenchymal Stem Cell Program (MSC) That Has Been Cleared for a Phase 1 Trial by the FDA to the Pipeline of COVID-19 Focused Rescue Therapies

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") announced today that it has entered into an exclusive license agreement with Personalized Stem Cells, Inc. (PSC) to acquire global rights to its adipose...

SRNE : 8.89 (-4.41%)
Sorrento COVID-19 R&D October 13, 2020 Pipeline Call Details Released

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today released details about its upcoming COVID-19 Pipeline Update call and webcast on October 13, 2020.

SRNE : 8.89 (-4.41%)
Sorrento Therapeutics (SRNE) Outpaces Stock Market Gains: What You Should Know

Sorrento Therapeutics (SRNE) closed the most recent trading day at $11.29, moving +0.98% from the previous trading session.

SRNE : 8.89 (-4.41%)
Thinking about buying stock in Gevo Inc, Intec Pharma, Advanced Micro Devices, Norwegian Cruise Line, or Sorrento Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GEVO, NTEC, AMD, NCLH, and SRNE.

AMD : 82.00 (-1.41%)
GEVO : 1.1100 (-9.02%)
NTEC : 0.2410 (-3.98%)
NCLH : 16.45 (+1.54%)
SRNE : 8.89 (-4.41%)
Sorrento Announces the Discovery of Salicyn-30 Small Molecule That Strongly Inhibits SARS-CoV-2 Infection in Preclinical Studies and Highlights its Place in a Potential Multi-Modal Therapy Strategy in Combination With Neutralizing Antibodies Against COVID-19

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") announced today that it has discovered a small molecule termed Salicyn-30 that demonstrated a potent 3-4 log reduction of SARS-CoV-2 virus infection...

SRNE : 8.89 (-4.41%)
Watch for Sorrento Therape to Potentially Pullback After Gaining 4.74% Yesterday

Sorrento Therape (NASDAQ:SRNE) traded in a range yesterday that spanned from a low of $10.71 to a high of $11.27. Yesterday, the shares gained 4.7%, which took the trading range above the 3-day high...

SRNE : 8.89 (-4.41%)
Scilex Holding Company, a Subsidiary of Sorrento Therapeutics, Announces Continuous Sales Growth in ZTlido(R) and Expects to Complete Enrollment on its SP-102 (SEMDEXA(TM)) Phase 3 Pivotal Trial Program in 2020

-- Preliminary Q3 2020 net sales of ZTlido of approximately $7.2 million, quarter-over-quarter growth of 26% compared to $5.7MM in Q2-2020 despite the continued impact of COVID-19 pandemic.

SRNE : 8.89 (-4.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and...

See More

Key Turning Points

2nd Resistance Point 9.70
1st Resistance Point 9.29
Last Price 8.89
1st Support Level 8.68
2nd Support Level 8.48

See More

52-Week High 19.39
Fibonacci 61.8% 12.54
Fibonacci 50% 10.42
Last Price 8.89
Fibonacci 38.2% 8.30
52-Week Low 1.45

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar